A Clinical Study of MIL93 in Solid Tumors.

Clinical trial NCT04671875 · UNKNOWN

Trial details

NCT number: NCT04671875
Sponsor: Beijing Mabworks Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2021-04-21
Primary completion: 2025-08-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.